<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000662458"><TermName>COPP</TermName><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat Hodgkin and non-Hodgkin lymphomas. It includes the drugs cyclophosphamide, vincristine sulfate (Oncovin), procarbazine hydrochloride, and prednisone. Also called COPP regimen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000734714" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;COPP&quot;" language="en" id="_3"/><SpanishTermName>COPP</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de un régimen de quimioterapia combinada que se usa para tratar linfomas de Hodgkin y no Hodgkin. Incluye los medicamentos ciclofosfamida, sulfato de vincristina (Oncovin), clorhidrato de procarbazina y prednisona. También se llama régimen COPP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-04-23</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000686548">COPP</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
